Product Overview
Across Gel® Dara Remove Kit
Daratumumab (DARA) is an anti-CD38 monoclonal antibody which has promising results in relapsed and refractory multiple myeloma. DARA interferes with blood compatibility testing by causing panagglutination in the Indirect Antiglobulin Test and Cross-Match. Across Dara Remove can over come anti-CD38 antibody interference in one simple step. It inhibits the agglutination effect of Daratumumab thus preventing the false-positive reaction in Cross-Match and Indirect Agglutination Tests. Across Dara Remove Kit block s the CD38 molecule on the surface of the RBC. When treating RBC with Across Dara Remove, RBC behaves as if no Daratumumab was present in the patient’s sample.
